Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Outset Medical (OM) EBT (2019 - 2026)

Outset Medical has reported EBT over the past 7 years, most recently at -$19.4 million for Q4 2025.

  • Quarterly EBT rose 24.36% to -$19.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$80.9 million through Dec 2025, up 36.51% year-over-year, with the annual reading at -$80.9 million for FY2025, 36.51% up from the prior year.
  • EBT was -$19.4 million for Q4 2025 at Outset Medical, down from -$17.4 million in the prior quarter.
  • Over five years, EBT peaked at -$17.4 million in Q3 2025 and troughed at -$46.1 million in Q3 2023.
  • The 5-year median for EBT is -$35.5 million (2022), against an average of -$33.8 million.
  • Year-over-year, EBT tumbled 45.21% in 2021 and then skyrocketed 46.25% in 2025.
  • A 5-year view of EBT shows it stood at -$41.1 million in 2021, then dropped by 0.66% to -$41.4 million in 2022, then increased by 6.99% to -$38.5 million in 2023, then soared by 33.38% to -$25.6 million in 2024, then grew by 24.36% to -$19.4 million in 2025.
  • Per Business Quant, the three most recent readings for OM's EBT are -$19.4 million (Q4 2025), -$17.4 million (Q3 2025), and -$18.4 million (Q2 2025).